Skip to main content

Table 2 Clinical, Laboratory and Imaging characteristics of the groups.

From: New clinical score to diagnose nonalcoholic steatohepatitis in obese patients

 

Non-NASH group

AVG (± SD)

NASH group

AVG (± SD)

P

Gender: % women

84.9

76.9

0.503

Age ( years)

39.8 (± 10.4)

44.6 (± 12.5)

0.216*

BMI ( Kg/m2)

46.3 (± 6.45)

47.0 (± 6.72)

0.714

HAS (% positive)

58.5

46.2

0.423

DM (% positive)

13.2

23.1

0.374

CT (mg/dL)

195.4 (± 37.28)

210.2 (± 22.3)

0.094*

LDL (mg/dL)

120 (± 35)

125.8 (± 22)

0.488

TG (mg/dL)

141.3 (± 57.5)

163 (± 111)

0.544

HDL (mg/dL)

49.0 (± 11.9)

48.9 (± 7.9)

0.968

FG (mg/dL)

103.2 (± 23.9)

100.5 (± 11.6)

0.589

AST (IU/L)

23.6 (± 9.2)

31.6 (± 22.4)

0.248*

ALT (IU/L)

24.5 (± 13.1)

44.8 (± 45)

0.151*

GGT (IU/L)

38.2(24.4)

46.5(18.5)

0.229*

AAR

1.000

0.7677

0.047**

ALP (IU/L)

170.2 (± 79.7)

159.6 (± 56.5)

0.659

SM (% positive)

67.4

66.7

0.960

US (% abnormal)

47

77

0.048**

  1. Data is expressed as Mean ± SD (except for AAR that has a non-parametric distribution).